𝔖 Bobbio Scriptorium

✦ LIBER ✦

Hexahydropyrimidines. VIII. Synthesis of 2-substituted 1,3-bis[4[N,N-bis(2-chloroethyl)amino]benzyl]hexahydropyrimidines as transport molecules for tumor inhibition

✍ Scribed by Billman, John H.; Khan, M. Sami

Book ID: 118042377
Publisher: American Chemical Society
Year: 1968
Tongue: English
Weight: 342 KB
Volume: 11
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm00308a028

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hexahydropyrimidines IX. Synthesis of 2-

Hexahydropyrimidines IX. Synthesis of 2-substituted-1,3-bis{2-methyl-4-[N,N-bis(2-chloroethyl)-amino]benzyl}hexahydropyrimidines as transport molecules for tumor inhibition

✍ John H. Billman; M. Sami Khan 📂 Article 📅 1968 🏛 John Wiley and Sons 🌐 English ⚖ 246 KB

Hexahydropyrimidines. IV. 1 Synthesis of

Hexahydropyrimidines. IV. 1 Synthesis of 2-[4-(N,N-Bis(2-chloroethyl)amino)aryl]-1,3-bis-(aralkyl) hexahydropyrimidines as Antitumor Agents 2

✍ Billman, John H.; Meisenheimer, John L. 📂 Article 📅 1964 🏛 American Chemical Society 🌐 English ⚖ 374 KB

Hexahydropyrimidines. III.1A Study of 2-

Hexahydropyrimidines. III.1A Study of 2-Substituted 1,3-Bis(p-methoxybenzyl)hexahydropyrimidines and 2-Substituted 1,3-Bis(p-chlorobenzyl)hexahydropyrimidines as Transport Molecules for Tumor Inhibition2

✍ Billman, John H.; Meisenheimer, John L. 📂 Article 📅 1963 🏛 American Chemical Society 🌐 English ⚖ 285 KB

Inhibitive properties, adsorption and a

Inhibitive properties, adsorption and a theoretical study of 3,5-bis(n-pyridyl)-4-amino-1,2,4-triazoles as corrosion inhibitors for mild steel in perchloric acid

✍ Mounim Lebrini; Michel Traisnel; Michel Lagrenée; Bouchaib Mernari; Fouad Bentis 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 198 KB

31 Potent inhibition of human immunodefi

31 Potent inhibition of human immunodeficiency virus (HIV) replication by aromatic linked bis-azamacrocycles: Synthesis and effects of substitution at the aromatic linker: R. Skerlj1, G. Bridger1, S. Padmanabhan1, D. Thornton2, M. Abrams1, G. Henson1, R. Datema3, N. Yamamoto4, K. De Vreese4, R. Pauwels4 and E. De Clercq4. 1Johnson Matthey Pharmaceutical Research, West Chester, Pennsylvania 19380, USA; 2Johnson Matthey Technology Centre, Sonning Common, Reading RG4 9NH, United Kingdom; 3Sandoz Forschungsinstitut, A-1235 Vienna, Austria; and 4Rega Institute for Medical Research, Katholieke Universtiteit Leuven, B-3000 Leuven, Belgium

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 73 KB